stockrowOrganon & Co.
OGNHealthcare Drug Manufacturers General
Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024.
- Revenue
- −1.75%
- EPS
- +1.64%
- Free cash flow
- +118.8%
- Total debt
- −3.10%
Quarter to September 2026, against a year earlier
Follow OGN
Alert me
Organon & Co. (OGN) Gross margin
Organon & Co.'s gross margin over the twelve months to 30 September 2026 was 53.1%, down 0.2 percentage points from fiscal 2025 (53.3%). Over the past ten years it has ranged from 52.0% (fiscal 2018) to 70.8% (fiscal 2019); the current reading is higher than 22% of that period. That is below the Drug Manufacturers General industry median of 73.0% and in line with the Healthcare sector median of 54.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 53.3% | (4.72) |
| FY2024 | 58.0% | (1.82) |
| FY2023 | 59.8% | (3.00) |
| FY2022 | 62.8% | 0.63 |
| FY2021 | 62.2% | (5.35) |
| FY2020 | 67.6% | (3.20) |
| FY2019 | 70.8% | 18.76 |
| FY2018 | 52.0% | (4.30) |
| FY2017 | 56.3% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 55.2% | 0.85 |
| Jun 2026 | 54.4% | 0.73 |
| Mar 2026 | 53.6% | 4.46 |
| Dec 2025 | 49.2% | (4.33) |
| 23 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NVO Novo Nordisk A/S compare | 80.9% |
| BIIB Biogen Inc. compare | 74.0% |
| SNY Sanofi compare | 73.4% |
| PFE Pfizer Inc. compare | 73.4% |
| GSK GSK PLC Sponsored ADR compare | 72.6% |
| BMY Bristol Myers Squibb Company compare | 69.2% |
| OGN Organon & Co. | 53.1% |
| AMRN Amarin Corporation PLC compare | 40.9% |
| GRFS Grifols, S.A. compare | 37.6% |
| Drug Manufacturers General industry median | 73.0% |
| Healthcare sector median | 54.5% |
| Market median | 46.0% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on OGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement